在急性心肌梗塞患者中,左心室功能的预后价值
Jorun Tangen1,2, Thuy Mi Nguyen1,2, Daniela Melichova1,3
1ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, P.O. Box 4950 Nydalen, 0424 Oslo, Norway.
Diagnostics (Basel, Switzerland)
|September 28, 2024
概括
左心房应变为急性心肌梗塞 (AMI) 患者,特别是心房动 (AF) 患者提供了宝贵的预后见解. LA储菌株独立预测心血管不良事件,可能在AF患者中表现优于传统措施.
科学领域:
- 心脏病学 心脏病学
- 心声回声扫描 (Echocardiography) 是一种心声回声扫描.
- 心血管成像 - 心血管成像
背景情况:
- 左心房 (LA) 体积是急性心肌梗塞 (AMI) 的已知预后标志物.
- 拉斯维加斯菌株分析提供了更深入的病理生理学理解.
- 特别是在心房动 (AF) 患者中,LA菌株的增量预后值需要进一步调查.
研究的目的:
- 为了评估LA体积和LA菌株在AMI患者的预后值.
- 为了确定LA菌株是否提供超出LA体积和左心室全球纵向菌株 (LV GLS) 的额外预后信息.
- 为了评估LA菌株的预后效用,特别是在有AF的AMI患者中.
主要方法:
- 对501名AMI患者进行前性研究,在入院72小时内接受二维心声谱.
- 主要结局:综合所有原因死亡率和主要心血管不良事件.
- 使用考克斯回归分析来评估主要结果的独立预测因素.
主要成果:
- 左心室全球纵向菌株 (LV GLS),索引LA体积 (LAVi) 和LA储菌株独立与主要结果相关.
- 在32名AF患者的小组中,LA储菌株仍然是显著的预测因素,而LV GLS和LAVi则没有.
- 在AF患者中,LA储菌株的预后值与LA体积和LV GLS相当,甚至可能超过.
结论:
- LA储菌株是AMI患者心血管不良事件的独立预测因子.
- 对LA菌株的分析提供了重要的预后信息,特别是在有AF的AMI患者中.
- 与AF亚组中的LA体积和LVGLS相比,LA储菌株可能具有更好的预后能力.
相关概念视频
Acute Coronary Syndrome III: Diagnostic studies
3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3
Mitral Stenosis II: Clinical features and Diagnostic Tests
6
Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
6
Mitral Regurgitation II: Clinical features and Diagnostic Tests
5
Mitral regurgitation (MR) is a valvular heart disorder in which the mitral valve fails to close tightly, allowing blood to leak backward into the heart. Understanding the clinical manifestations, assessment, diagnostic findings, and medical management of MR is crucial to effectively managing affected patients.Clinical Manifestations of Mitral RegurgitationMitral regurgitation can be acute or chronic, each presenting differently and requiring different approaches:1. Acute Mitral...
5
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
109
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
109


